Volume 23, Number 1Men's HealthContemporary Management of Male HypogonadismAndrew Y SunMale hypogonadism affects up to 40% of men and is becoming more prominent because of increasingly prevalent medical comorbidities. Because various forms of treatment are available today, physicians should discuss drug efficacy and safety while simultaneously ensuring that therapy forms are in alignment with patient preferences. Treatment adherence is critical to sustaining patient health outcomes.HypogonadismHormone replacementtestosterone deficiency
Volume 23, Number 1Men's HealthClinical Impact of a UroCuff Navigation Protocol for Patients With Medically Managed Benign Prostatic HyperplasiaAaron BergerArpeet ShahThis study conducted noninvasive urodynamic testing before renewing patients’ benign prostatic hyperplasia (BPH) medication prescriptions and assessed the impact of that urodynamic information on patients’ clinical course of treatment.UrodynamicsUrinary bladderProstatic hyperplasiapatient navigation